All sites C00-96,D32-33,D42-43,D45-47,D76 14992 89.8 2.9 3.5 1.1 2.7
Mouth, pharynx C00-14 233 96.8 1.0 0.6 0.5 1.0
  Lip C00 30 98.6 - 0.7 0.7 -
  Tongue C02 58 99.0 - - 0.7 0.3
  Mouth, other C03-06 69 97.4 - 0.3 0.6 1.7
  Salivary glands C07-08 30 89.3 5.4 2.7 0.7 2.0
  Pharynx C01,C09-14 47 97.0 1.7 0.4 - 0.9
Digestive organs C15-26 2717 80.7 3.2 9.0 2.5 4.6
  Oesophagus C15 84 93.1 0.5 2.6 2.1 1.7
  Stomach C16 268 93.7 0.5 2.0 1.2 2.5
  Small intestine C17 53 90.5 0.4 4.6 1.9 2.7
  Colon C18 930 94.7 0.2 2.2 0.9 2.0
  Rectum, rectosigmoid C19-20 424 97.0 - 1.0 0.8 1.2
  Anus C21 26 95.3 1.6 - 3.1 -
  Liver C22 175 68.0 5.8 17.6 3.8 4.8
  Gallbladder, bile ducts C23-24 153 60.5 8.0 17.6 3.7 10.2
  Pancreas C25 548 48.4 10.7 25.9 5.1 9.9
  Other digestive organs C26 56 39.3 2.9 18.2 14.6 25.0
Respiratory organs C30-39 870 67.2 15.1 10.1 2.6 5.0
  Nose, sinuses C30-31 16 97.5 - 1.3 1.3 -
  Larynx, epiglottis C32 15 98.7 - 1.3 - -
  Lung, trachea C33-34 821 66.8 15.9 10.1 2.7 4.6
  Mediastinum, pleura C38 9 34.8 10.9 37.0 - 17.4
Bone C40-41 18 90.0 1.1 5.6 - 3.3
Melanoma of the skin C43 631 99.9 0.0 - - 0.0
Skin, non-melanoma C44 770 99.8 0.0 0.0 0.1 0.1
Mesothelioma C45 19 98.9 1.1 - - -
Autonomic nervous system C47 3 100.0 - - - -
Soft tissues C48-49 113 97.7 0.5 0.4 0.4 1.1
Breast C50 4717 99.3 0.2 0.1 0.1 0.2
Female genital organs C51-58 1667 94.6 1.7 1.6 0.8 1.3
  Cervix uteri C53 154 97.7 1.0 0.5 0.8 -
  Corpus uteri C54 826 99.0 0.1 0.3 0.2 0.4
  Uterus, other C55,C58 10 38.0 6.0 22.0 14.0 20.0
  Ovary C56 470 88.4 4.1 3.8 1.3 2.4
  Other female genital C51-52,C57 207 91.6 2.7 1.4 1.8 2.5
Urinary organs C64-68 659 89.5 1.1 4.9 1.2 3.3
  Kidney C64 394 86.7 0.7 6.9 1.6 4.2
  Bladder and urinary tract2 C65-68 266 93.7 1.7 1.9 0.8 2.0
Eye C69 15 66.2 2.6 20.8 7.8 2.6
Brain, central nervous system C70-72,D32-33,D42-43 582 88.6 - 6.4 0.9 4.2
Thyroid gland C73 327 97.0 2.5 0.1 0.2 0.1
Other endocrine glands C74-75 14 87.5 - 5.6 1.4 5.6
Illdefined or unknown C76,C80 359 53.8 13.2 16.4 5.1 11.4
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 1277 79.5 8.6 1.6 1.5 8.7
  Hodgkin lymphoma C81 62 99.7 - - - 0.3
  Non-Hodgkin lymphoma C82-86,C96,D76 574 98.5 0.4 0.0 0.2 0.9
  Malignant immunoproliferative diseases C88 12 82.0 3.3 3.3 1.6 9.8
  Myeloma and other plasma cell tumors C90 186 62.8 10.4 9.4 4.2 13.2
  Leukaemia C91-95 273 64.2 21.3 0.6 2.1 11.8
  Myelodysplastic syndromes D46 60 30.4 21.4 1.3 2.7 44.1
  Myeloproliferaitive neoplasms D45,D47 111 62.0 15.6 0.5 2.2 19.7
Not included above
  Carcinoma in situ of the breast D05 393 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 950 100.0 - - - -
  Borderline tumour of the ovary D39 157 97.3 - 0.8 0.1 1.8
  Basal cell carcinoma of the skin 4545 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.